A panel of precision medicine experts from children’s hospitals take part in a conversation that highlights the work being done to improve the way rare diseases and pediatric cancer is diagnosed and treated.
Moderator: Samuel Blackman, MD, PhD, Co-Founder and Chief Medical Officer, Day One Biopharmaceuticals
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Speakers:
- Josh Bonkowsky, MD, PhD, Medical Director of the Primary Children’s Center for Personalized Medicine, Intermountain Healthcare
- Tomi Pastinen, MD, PhD, Director, Genomic Medicine Center, Children’s Mercy Kansas City
- Peter White, PhD, Senior Director of The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital